Skip to main content
. 2019 Jul 3;17:34. doi: 10.1186/s12969-019-0337-2

Table 3 Differences of IVIG-resistance risk assessment between patients with or without rs563535954

Risk score IVIG-unresponsive Patients OR(95%CI) P value
rs563535954 −/+ rs563535954 −/−
Risk Non-risk Risk Non-risk
Kobayashi 3 1 21 6 1.167(0.102–13.363) 1.000
Egami 1 3 23 5 13.800(1.178–161.719) 0.0393
Sano 2 2 19 8 2.375(0.283–19.925) 0.3871